Search research articles
Contact Us
Filters
Showing results (51-60 of 73) with videos related to
Page
of 8
Sort By:
Radiology
|
October 4, 2022
Multicenter Reproducibility of Liver Iron Quantification with 1.5-T and 3.0-T MRI
Diego Hernando, Ruiyang Zhao, Qing Yuan, et al.
Leukemia & Lymphoma
|
June 5, 2024
Safety and efficacy of fedratinib in patients with myelofibrosis previously treated with ruxolitinib: primary analysis of FREEDOM trial
Vikas Gupta, Abdulraheem Yacoub, Ruben A Mesa, et al.
Journal of Magnetic Resonance Imaging : JMRI
|
April 25, 2024
Practical Application of Multivendor MRI-Based R2* Mapping for Liver Iron Quantification at 1.5 T and 3.0 T
Gregory Simchick, Ruiyang Zhao, Qing Yuan, et al.
Blood Advances
|
September 7, 2021
Dasatinib and dexamethasone followed by hematopoietic cell transplantation for adults with Ph-positive ALL
Matthew J Wieduwilt, Jun Yin, Meir Wetzler, et al.
Magnetic Resonance in Medicine
|
September 6, 2024
Multicenter, multivendor validation of liver quantitative susceptibility mapping in patients with iron overload at 1.5 T and 3 T
Collin J Buelo, Julia Velikina, Lu Mao, et al.
Cancer
|
June 17, 2015
A phase 2 study of weekly temsirolimus and bortezomib for relapsed or refractory B-cell non-Hodgkin lymphoma: A Wisconsin Oncology Network study
Timothy S Fenske, Namrata M Shah, Kyung Mann Kim, et al.
Leukemia & Lymphoma
|
September 21, 2020
Comparison of salvage chemotherapy regimens and prognostic significance of minimal residual disease in relapsed/refractory acute myeloid leukemia
Muhammad Umair Mushtaq, Alexandra M Harrington, Sibgha Gull Chaudhary, et al.
Blood Advances
|
February 18, 2026
CRLF2-rearrangement and Extramedullary Disease in B-cell Acute Lymphoblastic Leukemia: A Possible Link?
Flavia Gava, Bonnie Yates, Zhouxin Sun, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 13, 2021
Lenalidomide-Epoetin Alfa Versus Lenalidomide Monotherapy in Myelodysplastic Syndromes Refractory to Recombinant Erythropoietin
Alan F List, Zhuoxin Sun, Amit Verma, et al.
Blood Advances
|
May 27, 2020
Real-world outcomes of adult B-cell acute lymphocytic leukemia patients treated with blinatumomab
Talha Badar, Aniko Szabo, Anjali Advani, et al.
Page
of 8
Search research articles
Search
Showing results (51-60 of 73) with videos related to
Sort By:
Page
of 8
Radiology
|
October 4, 2022
Multicenter Reproducibility of Liver Iron Quantification with 1.5-T and 3.0-T MRI
Diego Hernando, Ruiyang Zhao, Qing Yuan, et al.
Leukemia & Lymphoma
|
June 5, 2024
Safety and efficacy of fedratinib in patients with myelofibrosis previously treated with ruxolitinib: primary analysis of FREEDOM trial
Vikas Gupta, Abdulraheem Yacoub, Ruben A Mesa, et al.
Journal of Magnetic Resonance Imaging : JMRI
|
April 25, 2024
Practical Application of Multivendor MRI-Based R2* Mapping for Liver Iron Quantification at 1.5 T and 3.0 T
Gregory Simchick, Ruiyang Zhao, Qing Yuan, et al.
Blood Advances
|
September 7, 2021
Dasatinib and dexamethasone followed by hematopoietic cell transplantation for adults with Ph-positive ALL
Matthew J Wieduwilt, Jun Yin, Meir Wetzler, et al.
Magnetic Resonance in Medicine
|
September 6, 2024
Multicenter, multivendor validation of liver quantitative susceptibility mapping in patients with iron overload at 1.5 T and 3 T
Collin J Buelo, Julia Velikina, Lu Mao, et al.
Cancer
|
June 17, 2015
A phase 2 study of weekly temsirolimus and bortezomib for relapsed or refractory B-cell non-Hodgkin lymphoma: A Wisconsin Oncology Network study
Timothy S Fenske, Namrata M Shah, Kyung Mann Kim, et al.
Leukemia & Lymphoma
|
September 21, 2020
Comparison of salvage chemotherapy regimens and prognostic significance of minimal residual disease in relapsed/refractory acute myeloid leukemia
Muhammad Umair Mushtaq, Alexandra M Harrington, Sibgha Gull Chaudhary, et al.
Blood Advances
|
February 18, 2026
CRLF2-rearrangement and Extramedullary Disease in B-cell Acute Lymphoblastic Leukemia: A Possible Link?
Flavia Gava, Bonnie Yates, Zhouxin Sun, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 13, 2021
Lenalidomide-Epoetin Alfa Versus Lenalidomide Monotherapy in Myelodysplastic Syndromes Refractory to Recombinant Erythropoietin
Alan F List, Zhuoxin Sun, Amit Verma, et al.
Blood Advances
|
May 27, 2020
Real-world outcomes of adult B-cell acute lymphocytic leukemia patients treated with blinatumomab
Talha Badar, Aniko Szabo, Anjali Advani, et al.
Page
of 8